Science 37
Phase 3Science 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid Research
Founded
2014
Employees
51-200
Focus
Digital HealthClinical Trials
About
Science 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid Research
Funding History
4Total raised: $300M
IPO$200MUndisclosedSep 23, 2021
Series C$40MRedmile GroupSep 15, 2020
Series B$29MGlynn CapitalJan 15, 2018
Series A$31MLux CapitalAug 15, 2016
Company Info
TypePrivate
Founded2014
Employees51-200
LocationLos Angeles, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile